Lowest Price Guaranteed From USD 4,899
Published
July 2020
Pages
129
View Count
551
The ‘Pemphigus vulgaris Market: Pipeline Review, Developer Landscape and Competitive Insights, 2020-2030’ report delivers an in-depth understanding historical & forecasted epidemiology as well as the market trends of Pemphigus vulgaris across various geographical regions (North America, Europe and Asia-Pacific).
This report provides an informed opinion on the likely adoption of therapeutics designed to treat Pemphigus vulgaris. It features an in-depth analysis, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape and its growth prospects over the coming years, providing information about the product’s mechanism of action, dosage and administration, and pharmacological studies, regulatory milestones, and other development activities.
One of the key objectives of the report was to estimate the existing market size and the future opportunity of therapies for Pemphigus vulgaris, over the next decade. Based on multiple parameters, such as disease prevalence, anticipated adoption of the forecasted therapies and the likely selling price of such therapeutic products, we have provided informed estimates on the evolution of the market for the period 2020-2030.
1. PREFACE
2. EXECUTIVE SUMMARY
3. INTRODUCTION
4. CURRENT MARKET LANDSCAPE
4.1. Pemphigus vulgaris Treatment Therapies: Marketed and Development Pipeline
4.1.1. Analysis by Type of Molecule
4.1.2. Analysis by Phase of Development
4.1.3. Analysis by Mechanism of Action
4.1.4. Analysis by Route of Administration
4.1.5. Analysis by Dosage Form
4.1.6. Analysis by Target Patient Population
4.2. Pemphigus vulgaris: Developer Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size and Location of Headquarters
4.2.3. Analysis by Geography
5. COMPANY PROFILES
6. PARTNERSHIPS AND COLLABORATIONS
8. CLINICAL TRIAL ANALYSIS
9. PUBLICATION ANALYSIS
9. MARKET SIZING AND OPPORTUNITY ANALYSIS
9.1. Pemphigus vulgaris: Distribution by Type of Molecule
9.2. Pemphigus vulgaris: Distribution by Route of Administration
9.3. Pemphigus vulgaris: Distribution by Dosage Form
9.4. Pemphigus vulgaris: Distribution by Region
10. EXECUTIVE INSIGHTS
11. CONCLUDING REMARKS
12. APPENDIX 1: TABULATED DATA
13. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS